Article
AKT1 E17K in Colorectal Carcinoma Is Associated with BRAF V600E but Not MSI-H Status: A Clinicopathologic Comparison to PIK3CA Helical and Kinase Domain Mutants.
Molecular cancer research : MCR - 1 Jun 2015
Hechtman Jaclyn F, Sadowska Justyna, Huse Jason T, Borsu Laetitia, Yaeger Rona, Shia Jinru, Vakiani Efsevia, Ladanyi Marc, Arcila Maria E
Abstract excerpt
UNLABELLED: The PI3K/AKT/mTOR pathway is activated through multiple mechanisms in colorectal carcinoma. Here, the clinicopathologic and molecular features of AKT1 E17K-mutated colorectal carcinoma in comparison with PIK3CA-mutated colorectal carcinoma are described in detail. Interestingly, in comparison with PIK3CA mutants, AKT1 E17K was significantly associated with mucinous morphology and concurrent BRAF V600E...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
